In a report released today, Tore Svanberg from Stifel Nicolaus maintained a Buy rating on Credo Technology Group Holding Ltd (CRDO – Research ...
US Bancorp DE lifted its holdings in shares of Semtech Co. (NASDAQ:SMTC – Free Report) by 129.0% in the fourth quarter, ...
US Bancorp DE cut its position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 14.0% during the ...
Protagonist Therapeutics (NASDAQ:PTGX – Free Report) had its price objective hoisted by Truist Financial from $60.00 to $76.00 in a research note released on Tuesday morning,Benzinga reports. The firm ...
Investor Deadline: Investors who purchased or acquired SEMTECH securities during the Class Period may, no later than APRIL 22, 2025, seek to be appointed as a lead plaintiff representative of the ...
If you suffered losses exceeding $75,000 in Semtech between August 27, 2024 and February 7, 2025 and would like to discuss ...